TriLink Biotechnologies
https://www.trilinkbiotech.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From TriLink Biotechnologies
OliX Diversifies Into mRNA Amid Growing Global Interest
Amid the highly successful launch of COVID-19 vaccines using the technology by Pfizer/BioNTech and Moderna, South Korean bioventure OliX Pharmaceuticals is diversifying into the mRNA field by establishing a new subsidiary that focuses on R&D into new vaccines and therapeutics using the platform.
Company Information
- Industry
- In Vitro Diagnostics
- Research, Analytical Equipment & Supplies
- Services
- Contract Manufacturing Organization
-
Biotechnology
- Antisense, Oligonucleotides
- Synthesis Technologies, Production Processes
-
Drug Discovery Tools
- Genomics-Proteomics